Thank you, healthcare workers, for all you do. Your determination to help others is truly inspiring. Please stay safe.
Fundamentals of Exercise Physiology and T1D
Webcast Webcast

Fundamentals of Exercise Physiology and T1D

This activity was developed by Med-IQ in collaboration with JDRF.



Maximum Credits:

By clicking "Continue," you confirm that you have reviewed the CME information.

Webcast Webcast
By clicking "Continue," you confirm that you have reviewed the CME information.



Maximum Credits:
Webcast Webcast
By clicking "Continue," you confirm that you have reviewed the CME information.


Maximum Credits:

Overview: In this activity, Drs. Riddell and Gallen discuss the hormonal and metabolic response to various types of exercise and how those responses are different in the presence of type 1 diabetes. This program also explores the relationship between exercise and hyper- and hypoglycemia, as well as strategies for mitigating dysglycemia.

CME Information:

Aaron J. Kowalski, PhD
President and CEO
New York, NY

Ian Gallen, MD, CBE
Consultant Physician
Royal Berkshire FT and Community Diabetes Specialist
Berkshire West CCGs
United Kingdom

Michael Riddell, PhD
School of Kinesiology and Health Science
Muscle Health Research Centre
York University
Toronto, Canada

Activity Planners
Joseph Henske, MD, FACE 
Associate Professor 
Director of the Diabetes Program 
Division of Diabetes, Endocrinology, and Metabolism 
University of Arkansas for Medical Sciences 
Little Rock, AR 
Lori Laffel, MD, MPH 
Professor, Pediatrics 
Harvard Medical School 
Chief, Pediatric, Adolescent and Young Adult Section 
Head, Section on Clinical, Behavioral and Outcomes Research 
Joslin Diabetes Center 
Boston, MA 

Iñigo San Millán, PhD
Associate Research Professor
Department of Human Physiology and Nutrition
University of Colorado, Colorado Springs
Division of Endocrinology, Metabolism and Diabetes
Division of Sports Medicine
University of Colorado School of Medicine
Aurora, CO

Becky Sulik, RD, LD, CDE
Director of Education
Rocky Mountain Diabetes & Osteoporosis Center
Idaho Falls, ID
Eric Tozer
Co-founder & President, Diabetes Sports Project
San Marcos, CA
Sara C. Miller, MS, CPHQ
Director, QI Institute, CE Strategy and Content
Baltimore, MD
Samantha Gordon
CME Specialist
Baltimore, MD
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
East Lansing, MI
Kathleen (Helme) TumSuden
Manager, Mission
New York, NY
Sydney Yovic
AVP, Research Operations and Mission
New York, NY

Learning Objectives
Upon completion, participants should be able to:

  • Describe the hormonal and metabolic responses to various types of exercise
  • Illustrate the mechanisms for the maintenance of euglycemia as well as causes for hypoglycemia and hyperglycemia during and after exercise

Target Audience
This activity is intended for the healthcare team caring for those living with type 1 diabetes, including diabetologists, adult and pediatric endocrinologists, primary care physicians, endocrinology advanced practice providers, pharmacists, nurses, dietitians, CDEs, and other healthcare professionals.

Statement of Need
Type 1 diabetes (T1D) is a challenging condition to manage for a number of physiologic and behavioral reasons. Regular exercise is important to help people with T1D improve health and well-being, achieve target lipid profiles, improve body composition, and reach personal goals related to fitness and glycemic control. Integrating physical activity into daily life is challenging for anyone, but those with T1D face additional barriers related to the management of blood glucose levels before, during, and after exercise, including a fear of hypoglycemia, which prevents many from starting exercise programs. People with T1D tend to be at least as inactive as the general population, with a large percentage of individuals not maintaining a healthy body mass and not achieving the minimum recommended weekly amount of moderate to vigorous aerobic activity. The PEAK program addresses the need for education on safely and successfully planning for and managing different types of activity with T1D.

Collaboration Statement
This activity was developed by Med-IQ in collaboration with JDRF.


Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 
Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification Points
CME MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
CLAIMING MOC POINTS: If you intend to claim MOC points for your participation, you will need to provide your unique, six-digit ABIM ID Number. Please note, your name, ABIM ID number, birthdate and completion status will be shared with ABIM through the ACCME PARS system. Your points will be automatically submitted to the ABIM on your behalf; please allow 4 weeks for your points to display on the ABIM website.

Med-IQ is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This nursing activity has been approved for up to 0.75 contact hour.

ACPEMed-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.75 contact hour (0.075 CEUs) of credit for pharmacists. ACPE #0476-0000-19-008-H01-P. This knowledge-based activity is designed for all pharmacists. 

Instructions to Receive Credit
To receive credit, read the introductory CME/CE material, watch the Webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly. 

Initial Release Date: July 16, 2019 
Rerelease Date: July 15, 2020 
Expiration Date: July 14, 2021 
Estimated Time to Complete This Activity: 45 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Ian Gallen, MD, has indicated no real or apparent conflicts.
Michael Riddell, PhD
Consulting fees/advisory boards: Zucara Therapeutics 
Fees received for promotional/non-CME activities: Eli Lilly and Company, Insulet Corporation, Medtronic, Inc., Novo Nordisk
Aaron J. Kowalski, PhD, has indicated no real or apparent conflicts.
Joseph Henske, MD, FACE, has indicated no real or apparent conflicts.
Lori Laffel, MD, MPH
Consulting fees/advisory boards: Boehringer Ingelheim Pharmaceuticals, Inc., ConvaTec, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Insulet Corporation, Insulogic, Janssen Pharmaceuticals, Laxmi Pharma Equipments, LifeScan, Medtronic, Novo Nordisk, Sanofi-aventis U.S. Inc.
Iñigo San Millán, PhD
Ownership interest (stocks/stock options – excluding mutual funds):
Becky Sulik, RD, LD, CDE
Consulting fees/advisory boards: Lilly USA, LLC

Eric Tozer, has indicated no real or apparent conflicts.
Kathleen (Helme) TumSuden, has indicated no real or apparent conflicts.
Sydney Yovic, has indicated no real or apparent conflicts.
The peer reviewers and other activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, Med-IQ has a policy to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email



  • Operating system - Med-IQ supports the current operating system, plus two prior releases:
    • Android (eg, Samsung Galaxy)
    • Apple (eg, iPhone/iPad)
  • Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
    • Android (Chrome)
    • Apple (Safari)

Applications & Software

For technical assistance, please refer to our Support Manual.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.

The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy policy, please visit:

Acknowledgement of Support
This activity was funded in part by The Leona M. and Harry B. Helmsley Charitable Trust.

© 2019 JDRF


Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email For technical assistance, please refer to our support manual.

We recently updated our Privacy Notice and Terms of Use.